3-aminobenzamide has been researched along with Neoplasms in 11 studies
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diamandis, P | 1 |
Wildenhain, J | 1 |
Clarke, ID | 1 |
Sacher, AG | 1 |
Graham, J | 1 |
Bellows, DS | 1 |
Ling, EK | 1 |
Ward, RJ | 1 |
Jamieson, LG | 1 |
Tyers, M | 1 |
Dirks, PB | 1 |
Lin, R | 1 |
Elf, S | 1 |
Shan, C | 1 |
Kang, HB | 1 |
Ji, Q | 1 |
Zhou, L | 1 |
Hitosugi, T | 1 |
Zhang, L | 1 |
Zhang, S | 1 |
Seo, JH | 1 |
Xie, J | 1 |
Tucker, M | 1 |
Gu, TL | 1 |
Sudderth, J | 1 |
Jiang, L | 1 |
Mitsche, M | 1 |
DeBerardinis, RJ | 1 |
Wu, S | 1 |
Li, Y | 1 |
Mao, H | 1 |
Chen, PR | 1 |
Wang, D | 1 |
Chen, GZ | 1 |
Hurwitz, SJ | 1 |
Lonial, S | 1 |
Arellano, ML | 1 |
Khoury, HJ | 1 |
Khuri, FR | 1 |
Lee, BH | 1 |
Lei, Q | 1 |
Brat, DJ | 1 |
Ye, K | 1 |
Boggon, TJ | 1 |
He, C | 1 |
Kang, S | 1 |
Fan, J | 1 |
Chen, J | 1 |
DonĂ , F | 1 |
Chiodi, I | 1 |
Belgiovine, C | 1 |
Raineri, T | 1 |
Ricotti, R | 1 |
Mondello, C | 1 |
Scovassi, AI | 1 |
Wedge, SR | 1 |
Porteous, JK | 1 |
Newlands, ES | 1 |
Nagao, M | 1 |
Nakayasu, M | 1 |
Aonuma, S | 1 |
Shima, H | 1 |
Sugimura, T | 1 |
Thraves, PJ | 2 |
Mossman, KL | 2 |
Brennan, T | 1 |
Dritschilo, A | 2 |
Kelland, LR | 1 |
Burgess, L | 1 |
Steel, GG | 1 |
Frazier, DT | 1 |
Haince, JF | 1 |
Rouleau, M | 1 |
Hendzel, MJ | 1 |
Masson, JY | 1 |
Poirier, GG | 1 |
Sheridan, C | 1 |
Robins, P | 1 |
3 reviews available for 3-aminobenzamide and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.
Topics: Animals; Benzamides; Cell Transformation, Neoplastic; Humans; Neoplasms; Poly(ADP-ribose) Polymerase | 2013 |
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy.
Topics: DNA Repair; Gene Components; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Models, Molec | 2005 |
8 other studies available for 3-aminobenzamide and Neoplasms
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
Topics: Antineoplastic Agents, Alkylating; Benzamides; Carmustine; Dacarbazine; DNA Repair; Drug Screening A | 1996 |
Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors.
Topics: 3T3 Cells; Aminobenzoates; Animals; Benzamides; Benzoates; Benzoic Acid; Cell Differentiation; Cell | 1991 |
Differential radiosensitization of human tumour cells by 3-aminobenzamide and benzamide: inhibitors of poly(ADP-ribosylation).
Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; Humans; Neoplasms; Poly(ADP-ribose) Polymerase Inh | 1986 |
Differential radiosensitization by the poly(ADP-ribose) transferase inhibitor 3-aminobenzamide in human tumor cells of varying radiosensitivity.
Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; D | 1988 |
Inhibition of potentially lethal radiation damage repair in normal and neoplastic human cells by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation).
Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; Humans; In Vitro Techniques; Neoplasms | 1986 |
Genentech raises stakes on PARP inhibitors.
Topics: Drug Evaluation, Preclinical; Drug Industry; Enzyme Inhibitors; Humans; Indoles; Neoplasms; Poly(ADP | 2006 |
JPMorgan 25th annual healthcare conference. R&D at Merrimack, Inotek and Gemin X.
Topics: Delivery of Health Care; Drug Industry; Humans; Indoles; Neoplasms; Poly(ADP-ribose) Polymerase Inhi | 2007 |